Stock Trend Analysis Report
Prepared for you on Thursday, March 28, 2024.
Elevation Oncology, Inc. - Common stock (NASDAQ:ELEV)
Long-Term Uptrend (+90) - ELEV is in a strong uptrend that is likely to continue. While ELEV is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid ELEV?
MarketClub looks at technical strength and momentum to determine if the timing is right for ELEV.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
MarketClub’s Trade Triangles for ELEV
The long-term trend has been UP since Jan 5th, 2024 at 0.712
The intermediate-term trend has been UP since Jan 2nd, 2024 at 0.570
The short-term trend has been UP since Mar 15th, 2024 at 4.410
Smart Scan Analysis for ELEV
Based on our trend formula, ELEV is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
Open | High | Low | Price | Change |
---|---|---|---|---|
5.040 | 5.260 | 4.922 | 5.100 | +0.090 |
Prev. Close | Volume | Bid | Ask | Time |
5.010 | 260022 | 2024-03-28 13:18:48 |
52wk High | 5.89 | 52wk High Date | 2023-05-26 |
52wk Low | 0.363 | 52wk Low Date | 2023-11-13 |
Average Volume | 1,201,284 | Shares Outstanding | 48,651 |
Assets | 89,091,000M | Liabilities | 34,282,000M |